Jefferies Raises PT On HealthSpring To $48

Jefferies & Company has raised the price target on HealthSpring HS from $46 to $48 and maintains its Buy rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetAnalyst RatingsHealth CarehealthspringJefferies & CompanyManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!